Aigul Karabaeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aigul Karabaeva has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- D Tazhdinov
“Mediterra” Center of Modern Medicine
2 shared publications - Gulnaz Saduakassova
Kazakhstan-Russian Medical University
2 shared publications - A Medetbayeva
Private Clinic Almaty
1 shared publication - A Phaizullaeva
Kazakhstan-Russian Medical University
1 shared publication - Aigul Kozhakhmetova1 shared publication
- Aizada Urakova1 shared publication
Latest Publications
- Open Access
- 23 October 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Artificial Intelligence for Health Care System Resource Forecasting and Allocation in Urban Agglomerations: Systematic Review (Preprint)
BACKGROUND Health resource planning in urban agglomerations is complicated by spatial heterogeneity of demand, unequal infrastructure accessibility, and varying institutional workload. While artificial intelligence offers potential for forecasting personnel, finances, and material needs while accounting for territorial accessibility, the evidence base on artificial intelligence applicability across different resource types remains fragmented. OBJECTIVE To systematically identify, appraise, and synthesize studies on the application of artificial intelligence, machine learning, and quantitative algorithmic approaches to forecasting and allocating human, financial, and material health care resources in urban agglomeration settings. METHODS Publications from 2016 to July 2026 on the application of artificial intelligence, machine learning, and deep learning, predictive and simulation modeling, and optimization methods to forecast, plan, allocate, or assess accessibility of human, financial, or material health care resources in urban or territorial settings. PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar were searched from January 2016 to July 2026, supplemented by manual screening of reference lists. PROBAST, ROBINS-I, and the JBI Critical Appraisal Tools were applied according to study design by two independent reviewers, with a third expert in cases of disagreement. RESULTS Of 1021 records identified, 75 studies were included across four domains: human resources (n=18), financial resources (n=13), material/technical resources (n=32), and geographic accessibility (n=12). We found that: 1) across China the population-adjusted equity in health care worker distribution improved (Gini coefficient declined from 0.312 to 0.147) while the geographic equity remained poor (Gini 0.700-0.750). 2) decision-aware machine learning in Sierra Leone increased medicine consumption by an estimated 19%; 3) in the Netherlands, the number of radiology departments using artificial intelligence rose from 14 (2020) to 23 (2022), with a dedicated artificial intelligence budget in only 13 centers; 4) a surgical duration prediction model showed higher accuracy in identifying the risk of an overrun one hour in advance: 89% versus 80% for the Bayesian comparator. The heterogeneity of designs, resource types, outcomes, and performance metrics precluded meta-analysis. The predominance of studies from East Asia, particularly China, limits generalizability of the findings. CONCLUSIONS High predictive performance does not guarantee territorial equity. For implementation at the agglomeration level, exemplified by the Almaty agglomeration, artificial intelligence applications require local model validation, parallel assessment of population-adjusted provision and geographic accessibility, and prespecified measurable performance indicators. Artificial intelligence should serve as an analytical decision-support component rather than a replacement for health planning mechanisms.
- 23 October 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessArtificial Intelligence for Health Care System Resource Forecasting and Allocation in Urban Agglomerations: Systematic Review (Preprint)
BACKGROUND Health resource planning in urban agglomerations is complicated by spatial heterogeneity of demand, unequal infrastructure accessibility, and varying institutional workload. While artificial intelligence offers potential for forecasting personnel, finances, and material needs while accounting for territorial accessibility, the evidence base on artificial intelligence applicability across different resource types remains fragmented. OBJECTIVE To systematically identify, appraise, and synthesize studies on the application of artificial intelligence, machine learning, and quantitative algorithmic approaches to forecasting and allocating human, financial, and material health care resources in urban agglomeration settings. METHODS Publications from 2016 to July 2026 on the application of artificial intelligence, machine learning, and deep learning, predictive and simulation modeling, and optimization methods to forecast, plan, allocate, or assess accessibility of human, financial, or material health care resources in urban or territorial settings. PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar were searched from January 2016 to July 2026, supplemented by manual screening of reference lists. PROBAST, ROBINS-I, and the JBI Critical Appraisal Tools were applied according to study design by two independent reviewers, with a third expert in cases of disagreement. RESULTS Of 1021 records identified, 75 studies were included across four domains: human resources (n=18), financial resources (n=13), material/technical resources (n=32), and geographic accessibility (n=12). We found that: 1) across China the population-adjusted equity in health care worker distribution improved (Gini coefficient declined from 0.312 to 0.147) while the geographic equity remained poor (Gini 0.700-0.750). 2) decision-aware machine learning in Sierra Leone increased medicine consumption by an estimated 19%; 3) in the Netherlands, the number of radiology departments using artificial intelligence rose from 14 (2020) to 23 (2022), with a dedicated artificial intelligence budget in only 13 centers; 4) a surgical duration prediction model showed higher accuracy in identifying the risk of an overrun one hour in advance: 89% versus 80% for the Bayesian comparator. The heterogeneity of designs, resource types, outcomes, and performance metrics precluded meta-analysis. The predominance of studies from East Asia, particularly China, limits generalizability of the findings. CONCLUSIONS High predictive performance does not guarantee territorial equity. For implementation at the agglomeration level, exemplified by the Almaty agglomeration, artificial intelligence applications require local model validation, parallel assessment of population-adjusted provision and geographic accessibility, and prespecified measurable performance indicators. Artificial intelligence should serve as an analytical decision-support component rather than a replacement for health planning mechanisms.
- 31 December 2025
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY OF KAZAKHSTAN
- Vol. 85 (4) , 30
CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF PHARMACOLOGICAL ALDOSTERONE RECEPTOR BLOCKADE IN SUBTOTALLY NEPHRECTOMIZED WISTAR RATS
Background: This study evaluated the cardioprotective effect of spironolactone in Wistar rats subjected to 5/6 nephrectomy. Materials and Methods: Chronic kidney insufficiency was induced in Wistar rats via 5/6 nephrectomy. Animals were assigned to three groups: Group 1 — Chronic kidney insufficiency rats treated with spironolactone (0.2 mg/day), Group 2 — Chronic kidney insufficiency rats without treatment, and Group 3 — sham-operated controls. Before euthanasia, mean arterial pressure, heart rate, and 24-hour urine output were recorded. Plasma was analyzed for aldosterone, urea, creatinine, electrolytes, and total protein. The myocardial hypertrophy index was used to assess cardiac changes. Results: Heart rate did not differ significantly among groups. Mean arterial pressure was significantly higher in both Chronic kidney insufficiency groups than in controls (151.3 ± 2.7 mmHg in Group 1, 151.4 ± 2.3 mmHg in Group 2, vs. 121.15 ± 1.8 mmHg in controls, p0.05), whereas in Group 2 it was significantly greater (2.8 ± 0.11, p<0.05). Histological analysis revealed no arteriole wall thickening or connective tissue increase in Groups 1 and 3, while Group 2 showed pronounced arteriole wall thickening. Conclusion: Spironolactone-mediated aldosterone receptor blockade exerts a cardioprotective effect in Wistar rats with Chronic kidney insufficiency induced by 5/6 nephrectomy, independent of systemic Mean systemic arterial pressure changes.
- 31 December 2025
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY OF KAZAKHSTAN
- Vol. 85 (4) , 30
CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF PHARMACOLOGICAL ALDOSTERONE RECEPTOR BLOCKADE IN SUBTOTALLY NEPHRECTOMIZED WISTAR RATS
Background: This study evaluated the cardioprotective effect of spironolactone in Wistar rats subjected to 5/6 nephrectomy. Materials and Methods: Chronic kidney insufficiency was induced in Wistar rats via 5/6 nephrectomy. Animals were assigned to three groups: Group 1 — Chronic kidney insufficiency rats treated with spironolactone (0.2 mg/day), Group 2 — Chronic kidney insufficiency rats without treatment, and Group 3 — sham-operated controls. Before euthanasia, mean arterial pressure, heart rate, and 24-hour urine output were recorded. Plasma was analyzed for aldosterone, urea, creatinine, electrolytes, and total protein. The myocardial hypertrophy index was used to assess cardiac changes. Results: Heart rate did not differ significantly among groups. Mean arterial pressure was significantly higher in both Chronic kidney insufficiency groups than in controls (151.3 ± 2.7 mmHg in Group 1, 151.4 ± 2.3 mmHg in Group 2, vs. 121.15 ± 1.8 mmHg in controls, p0.05), whereas in Group 2 it was significantly greater (2.8 ± 0.11, p<0.05). Histological analysis revealed no arteriole wall thickening or connective tissue increase in Groups 1 and 3, while Group 2 showed pronounced arteriole wall thickening. Conclusion: Spironolactone-mediated aldosterone receptor blockade exerts a cardioprotective effect in Wistar rats with Chronic kidney insufficiency induced by 5/6 nephrectomy, independent of systemic Mean systemic arterial pressure changes.
- 31 December 2025
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY OF KAZAKHSTAN
- Vol. 85 (4) , 38
ECHOCARDIOGRAPHIC CHARACTERISTICS OF MYOCARDIAL STATUS IN PATIENTS WITH DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE AND ITS DYNAMICS IN DIALYSIS PATIENT UNDER SPIRONOLACTONE THERAPY
Background: The study aimed to evaluate myocardial status in patients with chronic kidney disease stages III–V and assess the effect of spironolactone in dialysis patients. Materials and Methods: A total of 46 patients with chronic kidney disease stages III–IV and 83 with stage V on maintenance hemodialysis were examined. Thirty-eight hemodialysis patients received spironolactone 25 mg/day for 6 months. Echocardiography was used to assess left ventricular dimensions, myocardial mass and relative wall thickness. Left ventricular hypertrophy was defined as left ventricular mass index ≥125 g/m² in men and ≥110 g/m² in women; relative wall thickness ≥0.45 was considered increased. Results: In spironolactone-treated patients (Group 1), left atrial diameter decreased from 4.58 ± 0.11 cm to 4.40 ± 0.11 cm; end-diastolic diameter from 4.15 ± 0.13 cm to 3.94 ± 0.17 cm; posterior wall thickness from 1.29 ± 0.03 cm to 1.23 ± 0.04 cm; Left ventricular myocardial mass from 238.46 ± 19.11 g to 206.18 ± 21.45 g; and Left ventricular mass index from 132.2 ± 10.81 g/m² to 113.32 ± 11.75 g/m². In untreated patients (Group 2), parameters showed minimal change: left atrial diameter 4.03 ± 0.11 cm to 3.90 ± 0.09 cm; Left ventricular myocardial mass 293.39 ± 17.13 g to 291.52 ± 15.43 g; Left ventricular mass index 173.57 ± 10.47 g/m² to 176.94 ± 10.06 g/m². Conclusion: In anuric hemodialysis patients, spironolactone 25 mg/day significantly reduced left ventricular posterior wall thickness, myocardial mass and volume, and left atrial size, indicating a cardioprotective effect.
- 31 December 2025
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY OF KAZAKHSTAN
- Vol. 85 (4) , 38
ECHOCARDIOGRAPHIC CHARACTERISTICS OF MYOCARDIAL STATUS IN PATIENTS WITH DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE AND ITS DYNAMICS IN DIALYSIS PATIENT UNDER SPIRONOLACTONE THERAPY
Background: The study aimed to evaluate myocardial status in patients with chronic kidney disease stages III–V and assess the effect of spironolactone in dialysis patients. Materials and Methods: A total of 46 patients with chronic kidney disease stages III–IV and 83 with stage V on maintenance hemodialysis were examined. Thirty-eight hemodialysis patients received spironolactone 25 mg/day for 6 months. Echocardiography was used to assess left ventricular dimensions, myocardial mass and relative wall thickness. Left ventricular hypertrophy was defined as left ventricular mass index ≥125 g/m² in men and ≥110 g/m² in women; relative wall thickness ≥0.45 was considered increased. Results: In spironolactone-treated patients (Group 1), left atrial diameter decreased from 4.58 ± 0.11 cm to 4.40 ± 0.11 cm; end-diastolic diameter from 4.15 ± 0.13 cm to 3.94 ± 0.17 cm; posterior wall thickness from 1.29 ± 0.03 cm to 1.23 ± 0.04 cm; Left ventricular myocardial mass from 238.46 ± 19.11 g to 206.18 ± 21.45 g; and Left ventricular mass index from 132.2 ± 10.81 g/m² to 113.32 ± 11.75 g/m². In untreated patients (Group 2), parameters showed minimal change: left atrial diameter 4.03 ± 0.11 cm to 3.90 ± 0.09 cm; Left ventricular myocardial mass 293.39 ± 17.13 g to 291.52 ± 15.43 g; Left ventricular mass index 173.57 ± 10.47 g/m² to 176.94 ± 10.06 g/m². Conclusion: In anuric hemodialysis patients, spironolactone 25 mg/day significantly reduced left ventricular posterior wall thickness, myocardial mass and volume, and left atrial size, indicating a cardioprotective effect.